{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T23:58:41Z","timestamp":1771891121736,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This study was supported by the Revitalizing Liaoning Talents Program-Medical Experts Project (No. YXMJ-JC-10)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,3,17]]},"DOI":"10.1038\/s41388-026-03679-y","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:35:20Z","timestamp":1770834920000},"page":"823-839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Upconversion mesoporous silica nanoparticles co-delivering celecoxib and rose bengal enable multimodal immunogenic and anti-angiogenic therapy for spinal metastasis of non-small cell lung cancer"],"prefix":"10.1038","volume":"45","author":[{"given":"Xinxin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3570-1811","authenticated-orcid":false,"given":"Ruoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7143-5552","authenticated-orcid":false,"given":"Xinlei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"3679_CR1","volume":"40","author":"J Yu","year":"2024","unstructured":"Yu J, Cai W, Zhou T, Men B, Chen S, Tu D, et al. CEACAM1 increased the lymphangiogenesis through miR-423-5p and NF- kB in Non-Small Cell Lung Cancer. Biochem Biophys Rep. 2024;40:101833.","journal-title":"Biochem Biophys Rep"},{"key":"3679_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ijrobp.2024.09.038","volume":"121","author":"MF Gensheimer","year":"2025","unstructured":"Gensheimer MF, Kotha NV, Vitzthum LK, Chin AL, Jackson S, van \u2019t Erve I, et al. A phase 2 single-arm trial of high-dose precision targeted radiation therapy added to immunotherapy for patients with metastatic non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2025;121:711\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3679_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4103\/jcrt.jcrt_1074_23","volume":"20","author":"L Wu","year":"2024","unstructured":"Wu L, Hu M, Li P, Man Q, Yuan Q, Zhang X, et al. Microwave ablation combined with percutaneous vertebroplasty for treating painful non-small cell lung cancer with spinal metastases under real-time temperature monitoring. J Cancer Res Ther. 2024;20:540\u20136.","journal-title":"J Cancer Res Ther"},{"key":"3679_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jtho.2015.10.001","volume":"11","author":"LEL Hendriks","year":"2016","unstructured":"Hendriks LEL, Hermans BCM, van den Beuken\u2014van Everdingen MHJ, Hochstenbag MMH, Dingemans A-MC. Effect of bisphosphonates, denosumab, and radioisotopes on bone pain and quality of life in patients with non\u2013small cell lung cancer and bone metastases: a systematic review. J Thorac Oncol. 2016;11:155\u201373.","journal-title":"J Thorac Oncol"},{"key":"3679_CR5","doi-asserted-by":"publisher","first-page":"E448","DOI":"10.1097\/BRS.0000000000002378","volume":"43","author":"H Uei","year":"2018","unstructured":"Uei H, Tokuhashi Y, Maseda M. Analysis of the relationship between the epidural spinal cord compression (ESCC) scale and paralysis caused by metastatic spine tumors. Spine. 2018;43:E448\u2013E455.","journal-title":"Spine"},{"key":"3679_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.14245\/ns.2142910.455","volume":"19","author":"L Wu","year":"2022","unstructured":"Wu L, Wang L, Yang J, Jia W, Xu Y. Clinical features, treatments, and prognosis of intramedullary spinal cord metastases from lung cancer: a case series and systematic review. Neurospine. 2022;19:65\u201376.","journal-title":"Neurospine"},{"key":"3679_CR7","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1227\/NEU.0b013e318207780c","volume":"68","author":"RT Arrigo","year":"2011","unstructured":"Arrigo RT, Kalanithi P, Cheng I, Alamin T, Carragee EJ, Mindea SA, et al. Predictors of survival after surgical treatment of spinal metastasis. Neurosurgery. 2011;68:674\u201381.","journal-title":"Neurosurgery"},{"key":"3679_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.semradonc.2022.11.006","volume":"33","author":"M Guckenberger","year":"2023","unstructured":"Guckenberger M, Dahele M, Ong WL, Sahgal A. Stereotactic body radiation therapy for spinal metastases: benefits and limitations. Semin Radiat Oncol. 2023;33:159\u201371.","journal-title":"Semin Radiat Oncol"},{"key":"3679_CR9","doi-asserted-by":"publisher","unstructured":"Jaipanya P, Chanplakorn P. Spinal metastasis: narrative reviews of the current evidence and treatment modalities. J Int Med Res. 2022;50. https:\/\/doi.org\/10.1177\/03000605221091665","DOI":"10.1177\/03000605221091665"},{"key":"3679_CR10","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1016\/j.ejca.2010.04.025","volume":"46","author":"R Harel","year":"2010","unstructured":"Harel R, Angelov L. Spine metastases: current treatments and future directions. Eur J Cancer. 2010;46:2696\u2013707.","journal-title":"Eur J Cancer"},{"key":"3679_CR11","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.62347\/XZRI9189","volume":"14","author":"Q Cai","year":"2024","unstructured":"Cai Q. Cancer-associated adipocytes in the ovarian cancer microenvironment. Am J Cancer Res. 2024;14:3259\u201379.","journal-title":"Am J Cancer Res"},{"key":"3679_CR12","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.7150\/ijbs.70958","volume":"18","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Guo S, Deng J, Shen J, Du F, Wu X, et al. VEGF\/VEGFR-targeted therapy and immunotherapy in non-small cell lung cancer: targeting the tumor microenvironment. Int J Biol Sci. 2022;18:3845\u201358.","journal-title":"Int J Biol Sci"},{"key":"3679_CR13","doi-asserted-by":"publisher","unstructured":"Wang Y, Chen R, Wa Y, Ding S, Yang Y, Liao J, et al. Tumor immune microenvironment and immunotherapy in brain metastasis from non-small cell lung cancer. Front. Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.829451.","DOI":"10.3389\/fimmu.2022.829451"},{"key":"3679_CR14","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1097\/CM9.0000000000002127","volume":"135","author":"W Liu","year":"2022","unstructured":"Liu W, Powell CA, Wang Q. Tumor microenvironment in lung cancer-derived brain metastasis. Chin Med J. 2022;135:1781\u201391.","journal-title":"Chin Med J"},{"key":"3679_CR15","doi-asserted-by":"publisher","unstructured":"Oliveira Santos M de J, Teles-Souza J, de Ara\u00fajo-Calumby RF, Copeland RL Jr, et al. Advances, limitations and perspectives in the use of celecoxib-loaded nanocarriers in therapeutics of cancer. Discover Nano. 2024;19. https:\/\/doi.org\/10.1186\/s11671-024-04070-0.","DOI":"10.1186\/s11671-024-04070-0"},{"key":"3679_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/13543776.2024.2373771","volume":"34","author":"M Mahboubi-Rabbani","year":"2024","unstructured":"Mahboubi-Rabbani M, Abdolghaffari AH, Ghesmati M, Amini A, Zarghi A. Selective COX-2 inhibitors as anticancer agents: a patent review (2018-23). Expert Opin Ther Pat. 2024;34:733\u201357.","journal-title":"Expert Opin Ther Pat"},{"key":"3679_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.34172\/apb.2024.055","volume":"14","author":"MM Akl","year":"2024","unstructured":"Akl MM, Ahmed A. Cytobiological alterations induced by celecoxib as an anticancer agent for breast and metastatic breast cancer. Adv Pharm Bull. 2024;14:604\u201312.","journal-title":"Adv Pharm Bull"},{"key":"3679_CR18","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.3390\/pharmaceutics15122785","volume":"15","author":"Z Xi","year":"2023","unstructured":"Xi Z, Jiang Y, Ma Z, Li Q, Xi X, Fan C, et al. Using mesoporous silica-based dual biomimetic nano-erythrocytes for an improved antitumor effect. Pharmaceutics. 2023;15:2785.","journal-title":"Pharmaceutics"},{"key":"3679_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122670","volume":"311","author":"Xiao","year":"2024","unstructured":"Xiao, Meng H, Songtao Li X, Li Z, Fang S, Wang Y, et al. Combined drug anti-deep vein thrombosis therapy based on platelet membrane biomimetic targeting nanotechnology. Biomaterials. 2024;311:122670.","journal-title":"Biomaterials"},{"key":"3679_CR20","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3390\/pharmaceutics13071067","volume":"13","author":"E Rastegari","year":"2021","unstructured":"Rastegari E, Hsiao Y-J, Lai W-Y, Lai Y-H, Yang T-C, Chen S-J, et al. An update on mesoporous silica nanoparticle applications in nanomedicine. Pharmaceutics. 2021;13:1067.","journal-title":"Pharmaceutics"},{"key":"3679_CR21","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1021\/cr5004198","volume":"115","author":"SS Lucky","year":"2015","unstructured":"Lucky SS, Soo KC, Zhang Y. Nanoparticles in photodynamic therapy. Chem Rev. 2015;115:1990\u20132042.","journal-title":"Chem Rev"},{"key":"3679_CR22","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.3390\/molecules29153546","volume":"29","author":"D Mudhakir","year":"2024","unstructured":"Mudhakir D, Sadaqa E, Permana Z, Mumtazah JE, Zefrina NF, Xeliem JN, et al. Dual-functionalized mesoporous silica nanoparticles for celecoxib delivery: amine grafting and imidazolyl pei gatekeepers for enhanced loading and controlled release with reduced toxicity. Molecules. 2024;29:3546.","journal-title":"Molecules"},{"key":"3679_CR23","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1016\/j.xphs.2019.06.011","volume":"108","author":"C Han","year":"2019","unstructured":"Han C, Zhang S, Huang H, Dong Y, Sui X, Jian B, et al. In vitro and in vivo evaluation of core\u2013shell mesoporous silica as a promising water-insoluble drug delivery system: improving the dissolution rate and bioavailability of celecoxib with needle-like crystallinity. J Pharm Sci. 2019;108:3225\u201332.","journal-title":"J Pharm Sci"},{"key":"3679_CR24","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.apsb.2020.04.011","volume":"10","author":"J Yu","year":"2020","unstructured":"Yu J, Wang Y, Zhou S, Li J, Wang J, Chi D, et al. Remote loading paclitaxel\u2013doxorubicin prodrug into liposomes for cancer combination therapy. Acta Pharm Sin B. 2020;10:1730\u201340.","journal-title":"Acta Pharm Sin B"},{"key":"3679_CR25","doi-asserted-by":"publisher","first-page":"19434","DOI":"10.1021\/jacs.4c05978","volume":"146","author":"J An","year":"2024","unstructured":"An J, Lv K-P, Chau CV, Lim JH, Parida R, Huang X, et al. Lutetium texaphyrin\u2013celecoxib conjugate as a potential immuno-photodynamic therapy agent. J Am Chem Soc. 2024;146:19434\u201348.","journal-title":"J Am Chem Soc"},{"key":"3679_CR26","doi-asserted-by":"publisher","unstructured":"Geng Y, Lou J, Wu J, Tao Z, Yang N, Kuang J, et al. NEMO-binding domain\/IKK\u03b3 inhibitory peptide alleviates neuronal pyroptosis in spinal cord injury by inhibiting ASMase-induced lysosome membrane permeabilization. Adv Sci. 2024;11. https:\/\/doi.org\/10.1002\/advs.202405759.","DOI":"10.1002\/advs.202405759"},{"key":"3679_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2011.01.023","volume":"304","author":"A Ferrario","year":"2011","unstructured":"Ferrario A, Lim S, Xu F, Luna M, Gaffney KJ, Petasis NA, et al. Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib. Cancer Lett. 2011;304:33\u201340.","journal-title":"Cancer Lett"},{"key":"3679_CR28","doi-asserted-by":"publisher","first-page":"59165","DOI":"10.1021\/acsami.3c13188","volume":"15","author":"R-J Kong","year":"2023","unstructured":"Kong R-J, Li Y-M, Huang J-Q, Yan N, Wu Y-Y, Cheng H. Self-delivery photodynamic re-educator enhanced tumor treatment by inducing immunogenic cell death and improving immunosuppressive microenvironments. ACS Appl Mater Interfaces. 2023;15:59165\u201374.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3679_CR29","doi-asserted-by":"publisher","unstructured":"Zhang W, Yu B, Chen X, Yan M, Liu Q, Liu Y, et al. Tumor homing chimeric peptide rhomboids to improve photodynamic performance by inhibiting therapy-upregulated cyclooxygenase-2. Small. 2024;20. https:\/\/doi.org\/10.1002\/smll.202309882.","DOI":"10.1002\/smll.202309882"},{"key":"3679_CR30","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.7150\/thno.41578","volume":"10","author":"W Sun","year":"2020","unstructured":"Sun W, Zhou Z, Pratx G, Chen X, Chen H. Nanoscintillator-mediated X-ray induced photodynamic therapy for deep-seated tumors: from concept to biomedical applications. Theranostics. 2020;10:1296\u2013318.","journal-title":"Theranostics"},{"key":"3679_CR31","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3390\/pharmaceutics16091135","volume":"16","author":"S Zhu","year":"2024","unstructured":"Zhu S, Lin S, Han R. Treating deep-seated tumors with radiodynamic therapy: progress and perspectives. Pharmaceutics. 2024;16:1135.","journal-title":"Pharmaceutics"},{"key":"3679_CR32","doi-asserted-by":"publisher","first-page":"110389","DOI":"10.1016\/j.biopha.2020.110389","volume":"129","author":"S Li","year":"2020","unstructured":"Li S, Jiang M, Wang L, Yu S. Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement. Biomedicine &amp. Pharmacotherapy. 2020;129:110389.","journal-title":"Pharmacotherapy"},{"key":"3679_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.radonc.2006.07.016","volume":"80","author":"A Debucquoy","year":"2006","unstructured":"Debucquoy A, Goethals L, Geboes K, Roels S, Mc Bride WH, Haustermans K. Molecular responses of rectal cancer to preoperative chemoradiation. Radiother Oncol. 2006;80:172\u20137.","journal-title":"Radiother Oncol"},{"key":"3679_CR34","doi-asserted-by":"publisher","first-page":"6437","DOI":"10.7150\/jca.47532","volume":"11","author":"J-W Hu","year":"2020","unstructured":"Hu J-W, Chen B, Zhang J, Qi Y-P, Liang J-H, Zhong J-H, et al. Novel combination of celecoxib and metformin improves the antitumor effect by inhibiting the growth of Hepatocellular Carcinoma. J Cancer. 2020;11:6437\u201344.","journal-title":"J Cancer"},{"key":"3679_CR35","doi-asserted-by":"publisher","unstructured":"Niu G, Bi X, Kang Y, Zhao H, Li R, Ding M, et al. An acceptor\u2013donor\u2013acceptor structured nano-aggregate for nir-triggered interventional photoimmunotherapy of cervical cancer. Adv Mater. 2024;36. https:\/\/doi.org\/10.1002\/adma.202407199.","DOI":"10.1002\/adma.202407199"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03679-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03679-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03679-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T23:02:58Z","timestamp":1771887778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03679-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,3,17]]}},"alternative-id":["3679"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03679-y","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"3 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}